Blood is thicker than water: The management of hyperviscosity in adults with cyanotic heart disease

Cardiology in Review

Volumn 15, Issue 1, 2007, Pages 31-34

  DeFilippis, Andrew Paul ^a   Law, Karen ^a   Curtin, Sarah ^b   Eckman, James R ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Family Medicine   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Congenital heart disease; Cyanotic heart disease; Hyperviscosity; Secondary polycythemia

Indexed keywords

DEXTRAN; FRESH FROZEN PLASMA; HEMOGLOBIN; HYDROXYUREA; IRON;

BLOOD TRANSFUSION; BLOOD VISCOSITY; CYANOTIC HEART DISEASE; DISEASE ASSOCIATION; ERYTHROCYTOSIS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERVISCOSITY SYNDROME; IRON DEFICIENCY; IRON THERAPY; MICROCYTOSIS; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHLEBOTOMY; POLYCYTHEMIA VERA; REVIEW; RISK ASSESSMENT; THROMBOSIS; TREATMENT OUTCOME;

BLOOD VISCOSITY; HEART DEFECTS, CONGENITAL; HEMATOCRIT; HUMANS; IRON, DIETARY; PHLEBOTOMY; POLYCYTHEMIA;

EID: 33845804255     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.crd.0000214959.82120.97     Document Type: Review

References (28)

1. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. Second of two parts. N Engl J Med. 2000;342:334-342.
2. Erslev AJ, Caro J. Secondary polycythemia: a boon or a burden? Blood Cells. 1984;10:177-191.
3. Baum VC. The adult patient with congenital heart disease. J Cardiothorac Vasc Anesth. 1996;10:261-282.
4. Hutton RD. The effect of iron deficiency on whole blood viscosity in polycythaemic patients. Br J Haematol. 1979;43:191-199.
5. Linderkamp O, Klose HJ, Betke K, et al. Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. J Pediatr. 1979;95:567-569.
6. Kaemmerer H, Fratz S, Braun SL, et al. Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease. Am J Cardiol. 2004;94:825-828.
7. Phornphutkul C, Rosenthal A, Nadas AS, et al. Cerebrovascular accidents in infants and children with cyanotic congenital heart disease. Am J Cardiol. 1973;32:329-334.
8. Wintrobe MM, Lee GR. Wintrobe's Clinical Hematology, 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
9. Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period: the Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005;26:2325-2333.
10. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol. 1996;28:768-772.
11. Perloff JK, Rosove MH, Child JS, et al. Adults with cyanotic congenital heart disease: hematologic management. Ann Intern Med. 1988;109:406-413.
12. Humphrey PR. Changes in cerebral blood flow relating to haematocrit and viscosity. Scand J Clin Lab Invest Suppl. 1981;156:209-211.
13. Grant P, Patel P, Singh S. Acute myocardial infarction secondary to polycythaemia in a case of cyanotic congenital heart disease. Int J Cardiol. 1985;9:108-110.
14. Yeager SB, Freed MD. Myocardial infarction as a manifestation of polycythemia in cyanotic heart disease. Am J Cardiol. 1984;53:952-953.
15. Rosenthal A, Nathan DG, Marty AT, et al. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation. 1970;42:297-308.
16. Oldershaw PJ, Sutton MG. Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease. Br Heart J. 1980;44:584-588.
17. York EL, Jones RL, Menon D, et al. Effects of secondary polycythemia on cerebral blood flow in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980;121:813-818.
18. Wade JP, Pearson TC, Russell RW, et al. Cerebral blood flow and blood viscosity in patients with polycythaemia secondary to hypoxic lung disease. BMJ. 1981;283:689-692.
19. Menon D, York EL, Bornstein RA, et al. Optimal hematocrit and blood viscosity in secondary polycythemia as determined from cerebral blood flow. Clin Invest Med. 1981;4:117-121.
20. Amitai Y, Blieden L, Shemtov A, et al. Cerebrovascular accidents in infants and children with congenital cyanotic heart disease. Isr J Med Sci. 1984;20:1143-1145.
21. Strong WB. Complications of polycythemia in patients who have cyanotic congenital heart disease. Pediatr Rev. 1992;13:379-380.
22. Cook JD, Lynch SR. The liabilities of iron deficiency. Blood. 1986;68:803-809.
23. Dallman PR. Manifestations of iron deficiency. Semin Hematol. 1982;19:19-30.
24. Finch CA, Miller LR, Inamdar AR, et al. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest. 1976;58:447-453.
25. Vongpatanasin W, Brickner ME, Hillis LD, et al. The Eisenmenger syndrome in adults. Ann Intern Med. 1998;128:745-755.
26. Triadou P, Maier-Redelsperger M, Krishnamoorty R, et al. Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. Nouv Rev Fr Hematol. 1994;36:367-372.
27. Murray JF, Gold P, Johnson BL Jr. Systemic oxygen transport in induced normovolemic anemia and polycythemia. Am J Physiol. 1962;203:720-724.
28. Castle WB, Jandl JH. Blood Viscosity and blood volume: opposing influences upon oxygen transport in polycythemia. Semin Hematol. 1966;3:193-198.